Member Info for Steveiom

TopCatz a profit is a profit my friend. There's no allegiance to this company or sympathy. If the MM's drop this to 8p I'm out. Happy with a profit if any kind from an AIM business. There's plenty of talking about amazing news flow on the run up to the AGM but I doubt it myself. I actually doubt whether all of the questions that have been sent in will be answered. I could sell now and make a few quid more but I'd rather play the game and stick to my guns on it. I do hope it comes good but I have a funny feeling we will be well below the 7p by the end of the week. If it ends up back down at 4p I'd certainly load up again. GLA though.

Oh well guys looks like my stop could be wiped out come Wednesday. If it is I wish you all the best of luck for the future. You'll need to be brave with no news, finger in the air and hope.

We're flying now. Huge demand coming in today. Can't keep up with the volume. That RNS has really generated the interest and inspired confidence. They might even have sold a bag of crisps given the small sp increase today ;)

Tradinglad the clinical trial was an independent trial just to establish the self use of the unit. Yes the outcome would go to the FDA but the 15 units is for the FDA. They could have used one unit for the clinical trial as it was all about following instructions. The start and finish date is all online including details of the independent tester. If this trial concluded on the date specified we should have been told the results. If it was pulled then I guess they might not need to tell us because the test would not have been conclusive.

Puma I am seriously thinking that this sitting on the news about the trial could be something to complain to the financial conduct authority. Information about a key trial can have a massive effect on the SP either way up or down. All the information is available online about the trial apart from the results. The start date and end date, what the trial was for and what would constitute a pass. All I can think of as to why we haven't been told is because there aren't any results. That the trial didn't go ahead, it was pulled for whatever reason hence why there are no results and no need to release an RNS. The more I think about it this can be the only explanation. If the trial did take place you cannot have directors with holding the results from the shareholders it would clearly give them an advantage. They had better up their game quick otherwise this SP is only going back to the 4p mark pretty quickly to.

Interesting article in the Guardian about global demand for oxygen devices. Belluscura released news on the measures put in place by the FDA to speed up the process of gaining approval. This was on the 22 March. We're almost 4 more months down the road, a clinical trial took place we believe and concluded in February and we still haven't heard anything from them. Has the FDA emergency exemption usage approval failed to speed up the process or has there been a complete failure on the part of those making the FDA submission.
Here's the Guardian article if anyone is interested.
https://amp-theguardian-com.cdn.ampproject.org/c/s/amp.theguardian.com/world/2020/jun/25/global-coronavirus-report-who-warns-of-global-shortage-of-oxygen-equipment
On another note when I asked them about the trial they refused to provide any information. Has anyone already got a question about the results of the trial in for the AGM.

Sparster ouch but on a positive there's probably a few sitting on a higher average. I'm leaving sentiment out on this one. We have great products but if we have a BOD who have lost sight of their smaller investors it's a no brainier. They are sat on news but have refused to release it for no reason. IMHO they may have fudged up the clinical trial and had to pull it, which if true makes them look like a bunch of jokers. Nothing to do with COVID quite simply impatience, trying to rush a process that needs to be done by professional people who have been successful with other FDA applications. If they don't get their act together the smaller investors will walk. Still hoping but I ain't losing out because the BOD are lazy with news.

Sparster not heard that one before :)

I will be out if this hits 8p with a small profit although I will be miffed but a profit is a profit. To be honest I still believe that the company has a great future but when you have a BOD that appear to have little to no comprehension of shareholder engagement especially when they are sat on news it does not fill me with confidence. No news is good news don't cut it unfortunately.

Apologies for double post, my bad guys it's been a long week.

Midas good to know that you are in Belluscura but all the information is online regarding the trial, does it not concern you that it finished way back in February yet we have not had an update on whether the Yanks can follow instructions :)

Midas good to know that you are in Belluscura but all the information is online regarding the trial, does it not concern you that it finished way back in February yet we have not had an update on whether the Yanks can follow instructions :)

They can drop this baby to 7p let's see who sells out. Total manipulation by the MM's. No good news no bad news just game playing.
I do still believe the BOD are playing a dangerous game sat on the Belluscura trial results and not informing share holders. This has to be very borderline especially if any of the directors have purchased or sold shares since the trial ended.

Some great opinions which are all valid but when it comes to FDA approval the do have timescales to follow and I don't totally agree that they are a law to themselves. They issue clear guidance on what is required along with a rough idea on how long the process takes. We have had a clinical trial for the userbility of the device and there's no reason why shareholders should not be informed of the outcome. It's a dangerous game for the BOD to sit tight on such information considering everything is online apart from the results. If it was a success and there is directors loading up that opens them right up to accusations of insider trading, likewise if they dump based upon crappy results of the trial. They have that information but refuse to share it with us. Regardless of the outcome of the trial, depending on how an RNS was presented it could stabilize the SP. Just a thought on the current lack of new flowing from those at the top.

Puma I'm starting to agree with that line of thought. They're either busy signing mega money making deals, sat on a pile of sh*t news wondering if it will go away on its own or sat on fantastic news that they don't want to release. They know exactly what happened in February with the Belluscura trial but are refusing to let share holders know the results of the trial. This is price sensitive information which should have been released IMHO to shareholders. It wasn't so my view is it didn't go well. I'm still up but I've got a sell set at 8p which still makes me a few quid. I do feel sorry for everyone who bought in on all the FDA promise and timescales but I still think we will come good. GLA

Interesting opinions guys and thanks for sharing. It's a strange move by Edale and you're all right only they will no their intentions. If there is shorting involved it's not going to take much for this to drop below 5p despite all the potential good news on the way. If we do start to see a plunge I seriously hope the BOD will fight it of with some facts and figures on Salarius progress and Belluscura clinical trial results.

I thought Edale spelt bad news when they were dumping left right and centre a few months back. I hope we aren't being shorted here, perhaps someone with a bit nowse could clear up the situation. Edale buy a few quids worth to lend out, they sell out at above 10p only to buy back in a few weeks time at around the 6/7p mark and give Edale their shares back. I don't know much about how it works but I hope it don't work like this.

This is really becoming quite boring now. No volume, totally manipulated by MM's and the BOD are very reluctant to give information that they have in the clinical trial that has concluded.
What questions has everyone sent in for the AGM. Hopefully they will give some decent answers.

I think the way the SP is dropping like a stone, any BOD with half a brain cell between them would be doing their best to shore up the SP with some decent news that is if there is any. Not asking for a made up story just a taste of how well these major salt deals are progressing or the results of the clinical trial. There'd be more chance of getting the results from the woman who conducted the trial than TEK at the moment. Feel free to give her a shout on LinkedIn Elvira Cawthon. A bottle of wine, bunch of flowers and a nice dinner and she might give us a bit of an update on whether the trial was a success or not.

The below is a snippet from what is available online for the Belluscura clinical trial. Now given the brief below, I'm presuming that most ppl with a little bit of intelligence could achieve a pass. It would have really kept the interest alive if they'd had let us know what's going on.

Primary Outcome Measures :
Ability to correctly assemble and use the X-PLO2R POC [ Time Frame: 2 hours ]
A subject who is able to follow the instructions to correctly assemble and receive oxygen through the X-PLO2R POC will be considered a study pass.A subject who is not able to follow the instructions and does not correctly assemble and receive oxygen through the X-PLO2R POC will be considered a study fail.